Cantargia Reports Presentation of New Preclinical Data Supporting CAN10 in Fibrotic Lung Diseases

LUND, SWEDEN / ACCESSWIRE / August 27, 2024 / Cantargia (STO:CANTA) Cantargia (Cantargia AB; Nasdaq Stockholm:CANTA) today reported presentation of new preclinical data providing support for CAN10 as a potential treatment of fibrotic lung diseases. …
Jetzt den vollständigen Artikel lesen